Kouzu Keita, Tsujimoto Hironori, Hiraki Shuichi, Nomura Shinsuke, Yamamoto Junji, Ueno Hideki
Department of Surgery, National Defense Medical College, Tokorozawa 359-8513, Japan.
Mol Clin Oncol. 2018 Jun;8(6):773-778. doi: 10.3892/mco.2018.1616. Epub 2018 Apr 24.
The preoperative diagnosis of T stage is important in selecting limited treatments, such as laparoscopic proximal gastrectomy (LPG), which lacks the ability to palpate the tumor. Therefore, the present study examined the accuracy of preoperative diagnosis of the depth of tumor invasion in early gastric cancer from the view point of the indication for LPG. A total of 193 patients with cT1 gastric cancer underwent LPG with gastrointestinal endoscopic examinations and a series of upper gastrointestinal radiographs. The patients with pT1 were classified into the correctly diagnosed group (163 patients, 84.5%), and those with pT2 or deeper were classified into the underestimated group (30 patients, 15.5%). Factors that were associated with underestimation of tumor depth were analyzed. Tumor size in the underestimated group was significantly larger; the lesions were more frequently located in the upper third of the stomach and were more histologically diffuse, scirrhous, with infiltrative growth, and more frequent lymphatic and venous invasion. For upper third lesions, in univariate analysis, histology (diffuse type) was associated with underestimation of tumor depth. Multivariate analysis found that tumor size (≥20 mm) and histology (diffuse type) were independently associated with underestimation of tumor depth. gastric cancer in the upper third of the stomach with diffuse type histology and >20 mm needs particular attention when considering the application of LPG.
术前T分期诊断对于选择有限治疗方法很重要,比如腹腔镜近端胃切除术(LPG),该术式无法触诊肿瘤。因此,本研究从LPG适应症角度探讨了早期胃癌术前肿瘤浸润深度诊断的准确性。共有193例cT1期胃癌患者接受了LPG,并进行了胃肠内镜检查和一系列上消化道造影。pT1期患者被归为正确诊断组(163例,84.5%),pT2期或更深分期患者被归为低估组(30例,15.5%)。分析了与肿瘤深度低估相关的因素。低估组的肿瘤大小明显更大;病变更常位于胃的上三分之一,组织学上更具弥漫性、硬癌,呈浸润性生长,且淋巴和静脉侵犯更频繁。对于上三分之一病变,单因素分析显示组织学类型(弥漫型)与肿瘤深度低估有关。多因素分析发现,肿瘤大小(≥20 mm)和组织学类型(弥漫型)与肿瘤深度低估独立相关。考虑应用LPG时,胃上三分之一伴有弥漫型组织学且肿瘤大小>20 mm的胃癌需要特别关注。